Xuanfei Qutan Tongluo Therapy In The Treatment Of Interstitial Lung Disease (phlegm Obstructing Lung Type) Clinical Study

Purpose:Interstitial lung disease（ILD）also known as diffuse parenchymal lung diseases（DPLD）,is a group of heterogenous disease collectively.Lesions occur mainly in the lung interstitium, but also relates to the alveolar wall andalveolar tissue around, and is often accompanied by the involvement of lung parenchyma,pulmonary fibrosis is a variety of different etiology of interstitial lung disease common ending.Because this disease is a disease of respiratory system in severe problems, present in thetreatment of the disease on combination of Chinese medicine and Western medicine is still inthe primary stage of exploration, and simple western medicine therapy in clinical curativeeffect not obvious. Chinese medicine for the treatment of the disease has a history of nearlyhundred years, and achieved good effect, the topics to Tongluo dissipating phlegm andremoving blood stasis method for the treatment of principle, to further standardize the newtreatment of interstitial lung disease （phlegm obstructing lung type）of TCM diagnosis andtreatment scheme, for the better clinical treatment to provide the basis.Method:60cases of interstitial lung disease （phlegm obstructing lung type）wererandomly divided into treatment and control groups,30cases in the treatment group weregiven interstitial Tongluo Decoction oral;30cases of the control group, hormone treatment,the daily prednisone,4weeks treatment, The two groups were observed before and aftertreatment in patients with single symptoms, signs, symptom scores, chest X-ray and safetytargets to improve the situation.Result: Clinical observations from the overall efficacy,30cases in the treatment group,the clinical cure in3cases （10%）,15cases （50%）, effective in7cases （23.33%）, invalidin5cases （16.67%）, the total efficiency of83.33%;30cases of the control group, theclinical cure in2cases（6.67%）,7cases（23.33%）, effective in10cases（33.33%）, invalidin11cases（36.67%）,the total efficiency of60%, Two groups of the total efficiency and theefficiency of clinical significant statistical processing of P <0.05, There were significantdifferences, can describe the effect of the treatment group was significantly better than thecontrol group. Above each process in the treatment of patients with no obvious adversereaction. Conclusion: By statistical analysis, Xuanfei Qutan Tongluo method on the treatment ofinterstitial lung disease in clinical symptoms, chest X-ray, have significantly improved effect,Data indicated that the treatment was significantly better than the control group. XuanfeiQutan Tongluo therapy in the treatment of interstitial lung disease （phlegm obstructing lungtype） with good clinical curative effect, convenient and safe, is a valuable treatment method.